Literature DB >> 19603288

Private cord blood banking: current use and clinical future.

Peter Hollands1, Catherina McCauley.   

Abstract

International private umbilical cord blood banking has expanded rapidly in recent years since the first cord blood transplant which was 20 years ago. Private companies offer parents the opportunity to store umbilical cord blood for the possible future use by their child or other family members. The private cord blood industry has been criticised by a number of professional bodies including the EU Ethics Committee, the Royal College of Obstetrics and Gynaecology, the Royal College of Midwives and the US College of Paediatrics. This review presents the arguments from the opponents of private cord blood banking, and then makes the case for private cord banking based on the latest scientific and clinical evidence.

Entities:  

Mesh:

Year:  2009        PMID: 19603288     DOI: 10.1007/s12015-009-9082-0

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  35 in total

1.  Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells.

Authors:  D K Kim; Y Fujiki; T Fukushima; H Ema; A Shibuya; H Nakauchi
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

2.  Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia.

Authors:  Franco Locatelli; Pietro De Stefano
Journal:  Haematologica       Date:  2005-12       Impact factor: 9.941

Review 3.  Adult umbilical cord blood transplantation: a comprehensive review.

Authors:  H Schoemans; K Theunissen; J Maertens; M Boogaerts; C Verfaillie; J Wagner
Journal:  Bone Marrow Transplant       Date:  2006-06-05       Impact factor: 5.483

4.  Development of mesenchymal stem cells partially originate from the neural crest.

Authors:  Satoru Morikawa; Yo Mabuchi; Kunimichi Niibe; Sadafumi Suzuki; Narihito Nagoshi; Takehiko Sunabori; Shigeto Shimmura; Yasuo Nagai; Taneaki Nakagawa; Hideyuki Okano; Yumi Matsuzaki
Journal:  Biochem Biophys Res Commun       Date:  2009-01-20       Impact factor: 3.575

Review 5.  Mesenchymal stem cells: characteristics and clinical applications.

Authors:  Sylwia Bobis; Danuta Jarocha; Marcin Majka
Journal:  Folia Histochem Cytobiol       Date:  2006       Impact factor: 1.698

6.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

7.  Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

Authors:  J N Barker; S M Davies; T DeFor; N K Ramsay; D J Weisdorf; J E Wagner
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 8.  Umbilical cord blood transplantation: pros, cons and beyond.

Authors:  Anfisa Stanevsky; Gal Goldstein; Arnon Nagler
Journal:  Blood Rev       Date:  2009-03-17       Impact factor: 8.250

9.  Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?

Authors:  Sergio Querol; Ghulam J Mufti; Steven G E Marsh; Antonio Pagliuca; Ann-Margaret Little; Bronwen E Shaw; Robert Jeffery; Joan Garcia; John M Goldman; J Alejandro Madrigal
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

Review 10.  Risk assessment in haematopoietic stem cell transplantation: stem cell source.

Authors:  Alvaro Urbano-Ispizua
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

View more
  10 in total

1.  Making the case for private cord blood banking: mission accomplished!: comment to Schmidt et al., Stem Cell Rev and Rep (2010) 6:234-236.

Authors:  Peter Hollands; Karl-Heinz Preisegger
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

2.  Making the case for private cord blood banking: mission failed! Comment to Hollands and McCauley, Stem Cell Rev and Rep 2009;5:195-203.

Authors:  Alexander H Schmidt; Alexander Platz; Claudia Rutt; Gerhard Ehninger
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

3.  The science and ethics of induced pluripotency: what will become of embryonic stem cells?

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

Review 4.  Biobanking for research in surgery: are surgeons in charge for advancing translational research or mere assistants in biomaterial and data preservation?

Authors:  Wolfgang E Thasler; Reinhard M K Thasler; Celine Schelcher; Karl-Walter Jauch
Journal:  Langenbecks Arch Surg       Date:  2013-02-22       Impact factor: 3.445

Review 5.  Umbilical cord blood banking: an update.

Authors:  Merlin G Butler; Jay E Menitove
Journal:  J Assist Reprod Genet       Date:  2011-05-27       Impact factor: 3.412

Review 6.  Stem cell-derived islet cells for transplantation.

Authors:  Juan Domínguez-Bendala; Luca Inverardi; Camillo Ricordi
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

7.  Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells.

Authors:  Jinglei Cai; Wen Li; Huanxing Su; Dajiang Qin; Jiayin Yang; Fan Zhu; Jianyong Xu; Wenzhi He; Xiangpeng Guo; Krystyna Labuda; Anja Peterbauer; Susanne Wolbank; Mei Zhong; Zhiyuan Li; Wutian Wu; Kwok-Fai So; Heinz Redl; Lingwen Zeng; Miguel Angel Esteban; Duanqing Pei
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

Review 8.  Concise review: mesenchymal stem cells for diabetes.

Authors:  Juan Domínguez-Bendala; Giacomo Lanzoni; Luca Inverardi; Camillo Ricordi
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

9.  Feasibility of Umbilical Cord Blood Collection in Neonates at Risk of Brain Damage-A Step Toward Autologous Cell Therapy for a High-risk Population.

Authors:  Angela Segler; Thorsten Braun; Hendrik Stefan Fischer; Ricarda Dukatz; Claire-Rachel Weiss; Alexander Schwickert; Carsten Jäger; Christoph Bührer; Wolfgang Henrich
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 10.  Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy.

Authors:  Carlo Petrini
Journal:  J Blood Med       Date:  2014-06-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.